Omigapil Maleate

• CAT Number: R028763
• CAS Number: 200189-97-5
• Molecular Formula: C23H21NO5
• Molecular Weight: 391.42
• Purity: ≥95%
• Synonyms: CGP 3466B Maleate; (2Z)-N-Methyl-N-2-propyn-1-yldibenz[b,f]oxepin-10-methanamine 2-Butenedioate; N-Methyl-N-2-propynyldibenz[b,f]oxepin-10-methanamine (2Z)-2-Butenedioate; N-Methyl-N-2-propynyldibenz[b,f]oxepin-10-methanamine (Z)-2-Butenedioate; CGP
• Target: Apoptosis
• Solubility: Soluble in DMSO > 10 mM
• Storage: Store at +4℃
• IUPAC Name: N-(benzo[b][1]benzoxepin-5-ylmethyl)-N-methylprop-2-yn-1-amine;(Z)-but-2-enedioic acid
• InChI: InChI=1S/C19H17NO.C4H4O4/c1-3-12-20(2)14-16-13-15-8-4-6-10-18(15)21-19-11-7-5-9-17(16)19;5-3(6)1-2-4(7)8/h1,4-11,13H,12,14H2,2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-
• InChIKey: SQAZQLMBEHYFJA-BTJKTKAUSA-N
• SMILES: CN(CC#C)CC1=CC2=CC=CC=C2OC3=CC=CC=C31.C(=CC(=O)O)C(=O)O

Omigapil maleate Cat No.: R028763 is a chemical compound that acts as an inhibitor of the enzyme protein farnesyltransferase. It has been studied for its potential in treating neurodegenerative disorders, particularly in the context of childhood diseases like neuronal ceroid lipofuscinosis (NCL). Omigapil works by preventing the accumulation of toxic proteins in cells, which is a hallmark of these conditions. Its mechanism of action suggests a potential therapeutic approach for other neurodegenerative diseases, although further clinical research is needed to confirm its efficacy and safety.